🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Profile
- Security Type
- Common Stock
- IPO
- 10/30/2026 · 9.37 Million Shares @ $15.00/share
Business: Aspen Neuroscience, Inc is a leading, clinical-stage regenerative medicine biotechnology company developing autologous induced pluripotent stem cell-derived (iPSC) therapies beginning with neurodegenerative diseases of high unmet need.
Company Contact
- CEO
- Damien McDevitt
- CFO
- Dalen Meeter
- Headquarters
- 10835 Road to the Cure, Suite 100, San Diego, CA 92121
- Phone
- 858-263-1222
- Investor Relations
- ir@aspenneuroscience.com